Targeted Therapies for Patients with HCC
Thomas A. Abrams, MD of Dana Farber Cancer Institute discusses how targeted therapies seem to work better for patients with HCC at the 2017 Gastrointestinal Cancers Symposium (ASCO GI) in San Francisc...
Author: obr
Added: 01/25/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts